PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Clinical Nuclear Medicine1 citations

Mimicking Metastatic Renal Cell Carcinoma

View Full Paper
JZJie ZangYPYumeng PengQLQun Liu

Key Points

  • To evaluate the diagnostic challenges of neuroendocrine neoplasms that can mimic metastatic renal cell carcinoma.
  • Patient case examination
  • Contrast-enhanced CT and MRI imaging
  • 68 Ga-LNC1007 PET/CT imaging
  • Surgical pathology confirmation
  • Initial imaging did not reveal malignancy.
  • PET/CT imaging indicated a significant radiotracer-avid lesion.
  • Surgical pathology confirmed the lesion as a neuroendocrine neoplasm rather than metastatic RCC.

Abstract

A 79-year-old patient with a history of renal cell carcinoma (RCC) presented with nonspecific upper abdominal pain 6 months ago. Contrast-enhanced CT and MRI did not reveal definitive evidence of malignancy. However, 68 Ga-LNC1007 ( 68 Ga-FAPI-RGD) PET/CT demonstrated a significant radiotracer-avid focus in the tail of the pancreas, initially interpreted as a metastatic RCC lesion. Surgical pathology later confirmed the lesion as a neuroendocrine neoplasm (NEN). This case illustrates that neuroendocrine tumors may occasionally be missed by conventional imaging modalities or suspected as other malignancies in certain scenarios, and highlights the potential diagnostic value of 68 Ga-LNC1007 PET/CT in detecting neuroendocrine tumors.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zang et al. (2026) studied this question.

synapsesocial.com/papers/69cf5ebc5a333a821460d4achttps://doi.org/10.1097/rlu.0000000000006385
Ask AI
Helpful
Bookmark
Share
View Full Paper